The invention relates to a
radioactive iodine marked Larotrectinib compound, and a preparation method and application thereof. The provided compounds comprise the
radioactive iodine marked Larotrectinib compound with the following
structural formula and analogues of the compound, wherein R1 and R2 are selected from a group consisting of H, F, Cl, Br, 123I, 124I, 125I, 130I and 131I, and at least one of R1 and R2 is a
radioactive iodine element. The invention provides the preparation method of the radioactive iodo-pyrazolo[1,5-a]
pyrimidine compound and a preparation method thereof. A long half-life period and different
ray energy of the radioactive iodo-pyrazolo[1,5-a]
pyrimidine compound can be used for
positron emission
tomography (PET) development, and can also be applied to
clinical diagnosis research of single-
photon emission
computed tomography (SPECT). Meanwhile, the high-energy radioactive iodo-pyrazolo[1,5-a]
pyrimidine can be used as a TrK
receptor ligand to inhibit activity ofTRK
kinase to kill
tumor cells, high-energy
iodine-131-
ray energy carried by the high-energy radioactive iodo-pyrazolo[1,5-a]pyrimidine can synergistically
shoot tumor cells, and an accurate radiotherapy effect is achieved.